Markets :: Specialty Chemicals :: Personal Care
Ashland earnings fall, but adjusted earnings beat estimates
4:13 PM MDT | July 31, 2014 | Vincent Valk
Ashland today reported fiscal third-quarter earnings from continuing operations down 20% year-on-year (YOY), to $71 million, or 90 cts/share, on sales down 1%, to $1.6 billion. Adjusted earnings from continuing operations – which exclude restructuring charges, pension adjustments, and other special items – totaled $1.63/share, up 24% YOY, and ahead of analysts’ consensus estimate of $1.57/share, as reported by Thomson Reuters (New York). Ashland has classified its water technologies business, which is being sold to private equity firm Clayton...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee